The Ampega companies are implementing a planned change in the leadership of their Investment Management division. Dr. Christoph Heidelbach will succeed Dr. Thomas Mann with effect from 1 January 2027. This transition is the result of a carefully prepared process, which will begin on 1 October 2026, when Dr. Heidelbach joins the Ampega management board. Dr. Thomas Mann will continue to be fully responsible for and lead the Investment Management division until the end of his term.
Dr. Jan Wicke, CFO of Talanx AG and Chairman of Ampega's Supervisory Board, commented on the appointment. He highlighted that in Dr. Christoph Heidelbach, they have gained an investment expert with many years of leadership experience and an established professional reputation in the market. Dr. Wicke expressed his conviction that Dr. Heidelbach, with his expertise, strategic foresight, and personality, will successfully further develop Ampega and provide future impetus.
Furthermore, Dr. Wicke stressed that Dr. Thomas Mann will continue his duties with full commitment until the end of the year. For customers and business partners of Ampega companies, this personnel change will have no impact on existing collaborations or business processes. Continuity in support and operational procedures is ensured, as all handover steps will be structured.
Professional Career and New Leadership Structure
Dr. Christoph Heidelbach has a long career in senior positions within Investment Management. Most recently, since 2019, he served as Chairman of the Management Board of Provinzial Asset Management GmbH. His experience in this demanding sector qualifies him for the upcoming role at Ampega. From 1 October 2026, he will strengthen the management board of Ampega companies in the Investment Management area, before assuming full responsibility for this division on 1 January 2027.
Parallel to this personnel realignment in Investment Management, the role of Speaker of the Management Board will also be newly filled. From 1 January 2027, Stefan Kampmeyer will hold this position. Mr. Kampmeyer has been a member of the Ampega companies' management board since 2023, thus ensuring an internal and smooth handover of this key position. These developments underscore Ampega's strategic focus on continuity and strengthening its leadership.
- —Dr. Christoph Heidelbach will join the Ampega management board on 1 October 2026.
- —From 1 January 2027, Dr. Heidelbach will assume overall responsibility for Investment Management.
- —Dr. Thomas Mann will be responsible for the Investment Management division until the end of his term.
- —Stefan Kampmeyer will become Speaker of Ampega's Management Board from 1 January 2027.
